BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 11073282)

  • 1. Hypertension in chronic renal failure and end-stage renal disease patients treated with haemodialysis or peritoneal dialysis.
    Bianchi G
    Nephrol Dial Transplant; 2000; 15 Suppl 5():105-10. PubMed ID: 11073282
    [No Abstract]   [Full Text] [Related]  

  • 2. Demographics of blood pressure and hypertension in children on renal replacement therapy in Europe.
    Kramer AM; van Stralen KJ; Jager KJ; Schaefer F; Verrina E; Seeman T; Lewis MA; Boehm M; Simonetti GD; Novljan G; Groothoff JW
    Kidney Int; 2011 Nov; 80(10):1092-8. PubMed ID: 21814180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension in dialysed children: the prevalence and therapeutic approach in Poland--a nationwide survey.
    Tkaczyk M; Nowicki M; Bałasz-Chmielewska I; Boguszewska-Baçzkowska H; Drozdz D; Kołłataj B; Jarmoliński T; Jobs K; Kiliś-Pstrusińska K; Leszczyńska B; Makulska I; Runowski D; Stankiewicz R; Szczepańska M; Wierciński R; Grenda R; Kanik A; Pietrzyk JA; Roszkowska-Blaim M; Szprynger K; Zachwieja J; Zajaczkowska MM; Zoch-Zwierz W; Zwolińska D; Zurowska A
    Nephrol Dial Transplant; 2006 Mar; 21(3):736-42. PubMed ID: 16303782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH).
    Sarafidis PA; Persu A; Agarwal R; Burnier M; de Leeuw P; Ferro CJ; Halimi JM; Heine GH; Jadoul M; Jarraya F; Kanbay M; Mallamaci F; Mark PB; Ortiz A; Parati G; Pontremoli R; Rossignol P; Ruilope L; Van der Niepen P; Vanholder R; Verhaar MC; Wiecek A; Wuerzner G; London GM; Zoccali C
    Nephrol Dial Transplant; 2017 Apr; 32(4):620-640. PubMed ID: 28340239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradialysis Hypertension in End-Stage Renal Disease Patients: Clinical Epidemiology, Pathogenesis, and Treatment.
    Georgianos PI; Sarafidis PA; Zoccali C
    Hypertension; 2015 Sep; 66(3):456-63. PubMed ID: 26150436
    [No Abstract]   [Full Text] [Related]  

  • 6. [Epidemiology of HTN in dialysis].
    Simon P
    Nephrol Ther; 2007 Oct; 3 Suppl 3():S143-9. PubMed ID: 18340679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistant hypertension in dialysis.
    Symonides B; Lewandowski J; Małyszko J
    Nephrol Dial Transplant; 2023 Aug; 38(9):1952-1959. PubMed ID: 36898677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure targets for hemodialysis patients.
    Turner JM; Peixoto AJ
    Kidney Int; 2017 Oct; 92(4):816-823. PubMed ID: 28938954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive Hemodialysis, Blood Pressure, and Antihypertensive Medication Use.
    Bakris GL; Burkart JM; Weinhandl ED; McCullough PA; Kraus MA
    Am J Kidney Dis; 2016 Nov; 68(5S1):S15-S23. PubMed ID: 27772639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Special situations: Intradialytic hypertension/chronic hypertension and intradialytic hypotension.
    Van Buren PN; Inrig JK
    Semin Dial; 2017 Nov; 30(6):545-552. PubMed ID: 28666072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension and the kidney.
    Krzesinski JM; Cohen EP
    Acta Clin Belg; 2007; 62(1):5-14. PubMed ID: 17451140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hypertension in renal failure patients: when do we overtreat? When do we undertreat?
    Rosansky SJ
    Blood Purif; 1996; 14(4):315-20. PubMed ID: 8873957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of antihypertensive drugs in the therapy of patients on regular dialysis treatment.
    Sulková S; Válek A
    Kidney Int Suppl; 1988 Sep; 25():S198-200. PubMed ID: 3184612
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute pancreatitis in peritoneal dialysis and haemodialysis: risk, clinical course, outcome, and possible aetiology.
    Bruno MJ; van Westerloo DJ; van Dorp WT; Dekker W; Ferwerda J; Tytgat GN; Schut NH
    Gut; 2000 Mar; 46(3):385-9. PubMed ID: 10673301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Haemodialysis 4 days a week: an effective alternative for controlling blood pressure and reaching target weight after dialysis].
    Molina Ordas A; Rodríguez Gómez MA; Sánchez Hernández R; Hernández-Reyes Luis MJ; Heras Benito M; Alvarez-Ude Cotera F
    Nefrologia; 2010; 30(3):369-70. PubMed ID: 20514107
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypertension in hemodialysis patients in Andalucia].
    García Cortés MJ; Ceballos M;
    Nefrologia; 2004; 24(2):149-57. PubMed ID: 15219090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effect of bromocriptine together with the established treatment for hypertension in patients undergoing peritoneal dialysis.
    Mejía-Rodríguez O; Alvarez-Aguilar C; Ledesma-Ramírez M; Paniagua-Sierra R
    Proc West Pharmacol Soc; 2004; 47():122-4. PubMed ID: 15633631
    [No Abstract]   [Full Text] [Related]  

  • 18. Current status of dialytic therapy in Korea.
    Kim SY; Jin DC; Bang BK
    Nephrology (Carlton); 2003 Oct; 8 Suppl():S2-9. PubMed ID: 15012684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension in hemodialysis patients.
    Querques M; Manunta P
    Minerva Urol Nefrol; 2010 Mar; 62(1):41-50. PubMed ID: 20424569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing dry weight and hypertension in dialysis patients: still a challenge for the nephrologist in 2009?
    Chazot C
    J Nephrol; 2009; 22(5):587-97. PubMed ID: 19809991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.